Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a related topic for Marinesco-Sjögren syndrome. Included a resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T15:40:48.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision v3.5.0 and removed Revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T05:29:45.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. The update appears to concern site versioning rather than the study details.
    Difference
    0.0%
    Check dated 2026-03-12T02:21:00.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The previous funding-status notice and Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:27:07.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added a government funding lapse notice. Updated the site to revision v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:50:50.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Glossary visibility was added and footer metadata was updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with capitalization changes in related labels.
    Difference
    0.2%
    Check dated 2026-01-28T04:49:11.000Z thumbnail image

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.